Global Nasogastric Tube Market Report and Forecast 2024-2032

Global Nasogastric Tube Market Report and Forecast 2024-2032


Global Nasogastric Tube Market Outlook

The global nasogastric tube market size was valued at USD 531.9 million in 2023, driven by increasing advancements in enteral feeding technologies across the globe. The market size is anticipated to grow at a CAGR of 5.3% during the forecast period of 2024-2032 to achieve a value of USD 846.6 million by 2032.

Nasogastric Tube: Introduction

A nasogastric tube, often abbreviated as NG tube, is a medical device used to administer fluids, medications, or nutrition directly into the stomach or to remove substances from the stomach. It is a flexible tube that is inserted through the nose and down the oesophagus into the stomach. The insertion of a nasogastric tube is typically performed by medical professionals, such as doctors, nurses, or trained healthcare providers.

The tube is measured and lubricated before being gently inserted through one nostril and advanced down the throat into the stomach. The correct placement is confirmed by checking the pH of the aspirated stomach contents or through imaging techniques like X-ray. Once the tube is in place, it can be secured to the patient's nose or cheek using tape or adhesive pads. Proper care and monitoring are necessary to prevent complications, such as displacement or infection. The length of time the nasogastric tube remains in place varies depending on the patient's condition and treatment requirements.

Key Trends in the Global Nasogastric TubeMarket

Some key trends in the nasogastric tube market:
  • Technological advancements: The nasogastric tube market has witnessed advancements in terms of tube materials, designs, and features. Manufacturers are developing innovative materials and coatings to improve tube flexibility, comfort, and reduce the risk of complications.
  • Increasing demand for enteral feeding: The demand for enteral feeding through nasogastric tubes is expected to rise due to the growing prevalence of chronic diseases, such as cancer, gastrointestinal disorders, and neurological conditions. Nasogastric tubes provide a convenient and cost-effective method for delivering nutrition to patients who cannot consume food orally.
  • Growing geriatric population: The global population is aging, leading to an increased number of elderly individuals who may require medical interventions, including nasogastric tube placement. Age-related conditions and diseases often necessitate the use of nasogastric tubes for feeding or medication administration, driving the demand in this market segment.
  • Home healthcare settings: There is a shift towards home-based care and outpatient settings for managing various medical conditions. Nasogastric tubes are increasingly being used in these settings as they offer a less invasive alternative to other feeding methods.
  • Focus on patient comfort and safety: Manufacturers are placing a greater emphasis on patient comfort and safety when designing nasogastric tubes. Efforts are being made to reduce discomfort during insertion and minimize the risk of complications such as nasal irritation, erosion, and pressure ulcers.
Global Nasogastric TubeMarket Segmentations

The market can be categorised into type, age group, end user, region.

Market Breakup by Type
  • Levin Catheter
  • Dobhoff Tube
  • Sengstaken-Blakemore Tube
  • Others
Market Breakup by Age Group
  • Adults
  • Paediatric
Market Breakup by End User
  • Hospitals
  • Paediatric Clinics
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Nasogastric Tube Market Overview

The exact market size of the nasogastric tube market is challenging to determine as it is a component of the broader enteral feeding devices market. However, the enteral feeding devices market, which includes nasogastric tubes, is projected to experience substantial growth. Factors driving this growth include the increasing prevalence of chronic diseases, a growing geriatric population, and advancements in enteral feeding technologies. The market is also influenced by factors such as healthcare expenditure, reimbursement policies, and regulatory frameworks in different regions.

The nasogastric tube market exhibits regional variations in terms of market size, demand patterns, and growth opportunities. Developed regions such as North America and Europe have well-established healthcare infrastructure and higher adoption rates of advanced medical devices. Regions including Asia Pacific, Latin America, and the Middle East and Africa are expected to witness significant market growth due to improving healthcare facilities, rising healthcare expenditure, and increasing awareness of enteral feeding methods.

Key Players in the Global Nasogastric Tube Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in nasogastric tube market are as follows:
  • Andersen Products Inc.
  • Bicakcilar A.S.
  • C.R. Bard Medical
  • Degania Silicone Ltd.
  • Pacific Hospital Supply Co. Ltd.
  • Cardinal Health
  • Guangdong Baihe Medical Technology
  • Rontis Medical
  • Poly Medicure Limited
  • SecurMed
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nasogastric Tube Market Overview
3.1 Global Nasogastric Tube Market Historical Value (2017-2023)
3.2 Global Nasogastric Tube Market Forecast Value (2024-2032)
4 Global Nasogastric Tube Market Landscape
4.1 Global Nasogastric Tube: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nasogastric Tube: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Age Group
4.2.3 Analysis by Applications
5 Global Nasogastric Tube Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nasogastric Tube Market Segmentation
6.1 Global Nasogastric Tube Market by Type
6.1.1 Market Overview
6.1.2 Levin Catheter
6.1.3 Dobhoff Tube
6.1.4 Sengstaken-Blakemore Tube
6.1.5 Others
6.2 Global Nasogastric Tube Market by Age Group
6.2.1 Market Overview
6.2.2 Adults
6.2.3 Pediatric
6.3 Global Nasogastric Tube Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Paediatric Clinics
6.3.4 Others
6.4 Global Nasogastric Tube Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Nasogastric Tube Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nasogastric Tube Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nasogastric Tube Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nasogastric Tube Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nasogastric Tube Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Andersen Products Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Bicakcilar A.S.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 C.R. Bard Medical
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Degania Silicone Ltd.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Pacific Hospital Supply Co. Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Cardinal Health
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Guangdong Baihe Medical Technology
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Rontis Medical
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Poly Medicure Limited
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 SecurMed
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings